KPMG UK has appointed Fiona Thomas as the firm’s new chief medical officer within its life sciences practice.
Thomas will act as KPMG UK’s senior medical adviser to clients across the healthcare space globally.
She joins from international biopharmaceutical company Swedish Orphan Biovitrum where she was UK medical director, and has also previously held senior roles with Sanofi Pasteur MSD and Biogen.
Prior to her 14-year career in the pharmaceutical industry, Thomas practiced as a physician in critical care and anaesthesia.
Originally from Glasgow, Thomas studied Medicine at the University of Glasgow and is registered with a licence to practice with the UK General Medical Council.
She said: “I’m pleased to be joining KPMG UK at a time of incredible growth for our Life Sciences practice, and to be working with clients across the healthcare industry. Throughout my career I’ve always been passionate about finding solutions that will ultimately bring advancement in medical practice and more positive outcomes for patients.
“As CMO it’s my aim to ensure our clients globally receive the best possible advice so they can successfully operate within the pharmaceutical industry for the benefit of patients.”
Head of KPMG UK’s Life Sciences Practice, Adrian Griffiths, added: “Fiona brings incredible experience as a practitioner and through her successful career working closely with the world’s largest pharmaceutical companies.
“Her experience, network and expertise will be a great asset to our Life Sciences practice, and we look forward to our clients benefiting from Fiona’s unique skillset as a senior medical adviser.”